6-16327684-ATGCTGCTGCTGCTGCTGCTGCTGCTGCTGC-ATGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGC
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_001128164.2(ATXN1):c.626_627insGCAGCA(p.Gln207_Gln208dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.089 ( 573 hom., cov: 20)
Exomes 𝑓: 0.059 ( 2232 hom. )
Failed GnomAD Quality Control
Consequence
ATXN1
NM_001128164.2 inframe_insertion
NM_001128164.2 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.106
Genes affected
ATXN1 (HGNC:10548): (ataxin 1) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 6-16327684-A-ATGCTGC is Benign according to our data. Variant chr6-16327684-A-ATGCTGC is described in ClinVar as [Likely_benign]. Clinvar id is 3057230.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN1 | NM_001128164.2 | c.626_627insGCAGCA | p.Gln207_Gln208dup | inframe_insertion | 7/8 | ENST00000436367.6 | NP_001121636.1 | |
ATXN1 | NM_000332.4 | c.626_627insGCAGCA | p.Gln207_Gln208dup | inframe_insertion | 8/9 | NP_000323.2 | ||
ATXN1 | NM_001357857.2 | c.*39_*40insGCAGCA | 3_prime_UTR_variant | 8/9 | NP_001344786.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN1 | ENST00000436367.6 | c.626_627insGCAGCA | p.Gln207_Gln208dup | inframe_insertion | 7/8 | 1 | NM_001128164.2 | ENSP00000416360 | P1 | |
ATXN1 | ENST00000244769.8 | c.626_627insGCAGCA | p.Gln207_Gln208dup | inframe_insertion | 8/9 | 1 | ENSP00000244769 | P1 | ||
ATXN1 | ENST00000642969.1 | downstream_gene_variant | ENSP00000493530 |
Frequencies
GnomAD3 genomes AF: 0.0887 AC: 11926AN: 134478Hom.: 569 Cov.: 20
GnomAD3 genomes
AF:
AC:
11926
AN:
134478
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0587 AC: 75114AN: 1278760Hom.: 2232 Cov.: 32 AF XY: 0.0592 AC XY: 37641AN XY: 635340
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
75114
AN:
1278760
Hom.:
Cov.:
32
AF XY:
AC XY:
37641
AN XY:
635340
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0887 AC: 11934AN: 134576Hom.: 573 Cov.: 20 AF XY: 0.0895 AC XY: 5855AN XY: 65426
GnomAD4 genome
AF:
AC:
11934
AN:
134576
Hom.:
Cov.:
20
AF XY:
AC XY:
5855
AN XY:
65426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ATXN1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 28, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at